Arcturus Gets Citi Upgrade After Positive Liver Disease Study Data – But BTIG Says Therapy’s Benefit Is Hard To Measure

Arcturus Therapeutics (ARCT) was in focus Thursday after promising Phase 2 data for its experimental treatment for a rare ...
Financial Times

Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform

ARCT-810 generally safe and well tolerated, demonstrating encouraging activity across key urea cycle biomarkers in ongoing Phase 2 study LUNAR 2.0™ produces greater than 30-fold higher protein ...

Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies

Detailed price information for Arcturus Therapeutics Ltd (ARCT-Q) from The Globe and Mail including charting and trades.
Forbes

Variant Arcturus Now Responsible For 14% Of New Covid Cases

The new omicron variant XBB.1.16, better known as arcturus, is now responsible for about 14% of new Covid cases, per the latest data from the Centers for Disease Control and Prevention (CDC). That's ...
earthsky

Arcturus, a northern springtime star

Arcturus and its constellation Bootes the Charioteer. Bootes has the shape of a kite. Tonight, look for the gloriously bright star Arcturus. From mid-northern latitudes at this time of year, it rises ...
Medical Xpress

Arcturus: what to know about the new COVID variant, omicron XBB.1.16

A new COVID variant XBB.1.16, or "Arcturus," has now been identified in at least 34 countries including the UK. Arcturus is a subvariant of omicron and was first detected in India in January 2023.